NEWS

EVIR THERAPEUTICS

We are a preclinical-stage biotechnology company pioneering the development of engineered dendritic cell vaccines for cancer therapy.

At EVIR Therapeutics, we use gene-modified dendritic cells to activate the immune system against cancer.